Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Conmed Q1 Adj. EPS $0.95 Beats $0.81 Estimate, Sales $321.30M Beat $313.37M Estimate

Author: Benzinga Newsdesk | April 30, 2025 05:17pm
Conmed (NYSE:CNMD) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.81 by 17.28 percent. This is a 20.25 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $321.30 million which beat the analyst consensus estimate of $313.37 million by 2.53 percent. This is a 2.89 percent increase over sales of $312.27 million the same period last year.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist